Skip to main content

1 Result(s)

within Lucas J. Huebner Remove this filter

and

  1. No Access

    Article

    Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial

    The prospective randomized, placebo-controlled CALGB 10603/RATIFY trial (Alliance) demonstrated a statistically significant overall survival benefit from the addition of midostaurin to standard frontline chemo...

    Richard A. Larson, Sumithra J. Mandrekar, Lucas J. Huebner, Ben L. Sanford… in Leukemia (2021)